Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, discusses treatment implications for clinicians managing chronic insomnia and potential comorbid conditions.
Clinicians need to understand the significance of insomnia, how it’s affecting the patient, and whether there are other conditions that need to be treated along with the insomnia, said Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine.
Transcript
What knowledge gaps among clinicians continue to impact diagnosis and treatment of chronic insomnia?
Well, I think the important thing is to recognize if insomnia is existing by itself or whether it's comorbid with other disorders. Most often it is comorbid with some other disorder, particularly a psychiatric or a medical disorder. So, clinicians really need to understand the significance of insomnia, how it’s affecting the patient, and whether there are other conditions that need to be treated along with the insomnia.
Too often people will see somebody who has a medical or psychiatric disorder and think that the primary treatment of the medical or the psychiatric disorder will eliminate the sleep disturbance, but usually it doesn't. You need to treat both at once—both the insomnia and the underlying medical or psychiatric disorder.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More